Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
3.
Mt Sinai J Med ; 66(1): 31-4, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9989103

ABSTRACT

The objective of this study is to evaluate the clinical aspects of laparoscopic management of adnexal masses. The feasibility of this approach has been demonstrated, but the safe and effective use of laparoscopy for this indication requires training, technical skills and experience on the part of the laparoscopist. If used appropriately, many patients will benefit from minimally-invasive surgery. We compared clinical factors of patients having laparoscopy to those having laparotomy in a case-control study of 30 patients with adnexal masses. Oophorectomy or ovarian cystectomy was performed by laparoscopy for 20 women and by laparotomy for 10 women. Comparing the 2 groups, the most significant difference was the decrease in length of hospital stay in the laparoscopy group. There were no significant differences in operative time or intraoperative complications. Estimated blood loss was lower in the laparoscopy group, and no intraoperative complications occurred. No patient required conversion from laparoscopy to laparotomy. All patients had benign disease despite the inclusion of patients with risk factors for ovarian carcinoma. This study clearly demonstrates the clinical benefits of laparoscopic management of adnexal masses treated with oophorectomy or ovarian cystectomy.


Subject(s)
Adnexal Diseases/surgery , Laparoscopy , Adnexal Diseases/diagnosis , Adult , Aged , Blood Loss, Surgical , CA-125 Antigen/blood , Case-Control Studies , Female , Humans , Length of Stay , Middle Aged
4.
Psychosomatics ; 39(3): 273-80, 1998.
Article in English | MEDLINE | ID: mdl-9664774

ABSTRACT

To determine the difference in length of hospital stay for geriatric medical-surgical inpatients with or without psychiatric comorbidity, the authors prospectively interviewed 467 admissions by using the Structured Clinical Interview for DSM-III-R and the Mini-Mental State Exam. At admission, 208 (44.5%) inpatients had a current psychiatric comorbidity, 51 (10.9%) had an anxiety disorder, 88 (18.8%) had a depressive disorder, and 126 (27%) had cognitive impairment. The patients with cognitive impairment had a significantly prolonged hospital stay compared with those without cognitive impairment (14.6 vs. 10.6 days). No difference existed in length of stay for the patients with and without anxiety disorders (11.6 vs. 11.6 days) or depressive disorders (11.0 vs 11.8 days). In view of the limited resources available for screening elderly medical-surgical inpatients for psychiatric comorbidity, this study suggests the utility of identifying cognitive impairment and targeting it for interventions to reduce the clinical burden and to decrease hospital stays.


Subject(s)
Anxiety Disorders/epidemiology , Dementia/epidemiology , Depressive Disorder/epidemiology , Length of Stay/statistics & numerical data , Aged , Aged, 80 and over , Anxiety Disorders/diagnosis , Anxiety Disorders/psychology , Comorbidity , Dementia/diagnosis , Dementia/psychology , Depressive Disorder/diagnosis , Depressive Disorder/psychology , Female , Humans , Male , Mass Screening , Patient Care Team , Prospective Studies , Sick Role
5.
Ann Intern Med ; 126(6): 468-79, 1997 Mar 15.
Article in English | MEDLINE | ID: mdl-9072935

ABSTRACT

PURPOSE: To evaluate the potential benefits, harms, and economic consequences of digital rectal examination and measurement of prostate-specific antigen (PSA) for the early detection of prostate cancer. DATA SOURCES: Relevant studies were identified from a MEDLINE search (1966 to 1995), reviews, bibliographies of retrieved articles, author files, and abstracts. STUDY SELECTION: Probabilities for individual clinical outcomes were derived from various sources, including the largest screening study of community volunteers to data, analyses of Medicare claims, and recently published meta-analyses of the outcomes of alternative treatment strategies. Cost estimates were based on the 1992 Medicare fee schedule. DATA EXTRACTION: A cost-effectiveness model for one-time digital rectal examination and PSA measurement was constructed to examine the possible outcomes. RESULTS: If a favorable set of assumptions is used, one-time digital rectal examination and PSA measurement may increase average life expectancy by approximately 2 weeks at a reasonable marginal cost for men who are between 50 and 69 years of age. Considerable iatrogenic illness would occur. If less favorable assumptions are used, the estimated net benefit would decrease and cost-effectiveness ratios would dramatically increase. Even if favorable assumptions are used, the model suggests that screening adds only a few days to the average life expectancy of men who are older than 69 years of age. If the assumptions are less favorable, older men are harmed. CONCLUSIONS: The model suggests that screening may be reasonable in younger men if optimistic assumptions consistent with existing observational data are made. The lack of direct evidence showing a net benefit of screening for prostate cancer seems to mandate more clinician-patient discussion for this procedure than for many other routine tests.


Subject(s)
Mass Screening/economics , Physical Examination/economics , Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/economics , Aged , Cost-Benefit Analysis , Humans , Male , Mass Screening/methods , Middle Aged , Models, Economic , Physical Examination/methods , Probability , Prostatic Neoplasms/therapy , Rectum , Risk Factors , Treatment Outcome
7.
J Acquir Immune Defic Syndr Hum Retrovirol ; 13(5): 416-21, 1996 Dec 15.
Article in English | MEDLINE | ID: mdl-8970467

ABSTRACT

Hospitals are a major provider of medical care for human immunodeficiency virus (HIV)-infected persons. Although utilization and patterns of care profiles in public and private hospitals have been evaluated for acquired immunodeficiency syndrome (AIDS)-related Pneumocystis carinii pneumonia (PCP), one of the most costly and common severe complications of AIDS, information from Veterans Administration (VA) hospitals has not been reported previously. This article reports on inpatient care for PCP patients by obtaining data from VA, private, and public hospitals. Cost and resource utilization data were obtained from reviews of medical records, claims, and provider bills from 26 non-VA hospitals and 18 VA hospitals in 10 cities in the United States. Data on severity of illness, patterns of care, and outcomes for PCP were obtained from medical record reviews from 2,174 PCP cases treated in 82 non-VA and 14 VA hospitals in five U.S. cities. Estimates were made of the average costs and the rates of use of diagnostic tests, anti-PCP medications, and intensive care units for samples of public hospital, private hospital, and VA patients with PCP. With mean charges for a single PCP episode of $14,500 to $16,060, PCP remains one of thea most costly complications of AIDS. Although the severity of PCP illness at admission was greatest at public hospitals, the intensity of care was lowest: for frequency of cytologic diagnosis (48% at public, 62% at VA, and 66% at private hospitals), bronchoscopy (45% at public, 60% at VA, and 66% at private hospitals), and intensive care unit use (11% at public, 22% at VA, and 19% at private hospitals). In-hospital mortality rates for PCP also differed in the three types of hospitals (20% at public, 24% at VA, and 18% at private hospitals). Patterns of PCP care differ among VA, public, and private hospitals. Future studies on the HIV epidemic should include data collected from uniform data sources from VA hospitals, in addition to public and private hospitals, to provide insight on the processes of care and outcomes for HIV-infected persons.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Hospitals/statistics & numerical data , Pneumonia, Pneumocystis/epidemiology , AIDS-Related Opportunistic Infections/economics , AIDS-Related Opportunistic Infections/therapy , Adult , Female , Humans , Male , Pneumonia, Pneumocystis/economics , Pneumonia, Pneumocystis/therapy , Severity of Illness Index , Treatment Outcome , United States/epidemiology , United States Department of Veterans Affairs , Utilization Review
8.
Int J Pediatr Otorhinolaryngol ; 38(2): 115-30, 1996 Dec 20.
Article in English | MEDLINE | ID: mdl-9119600

ABSTRACT

OBJECTIVE: To evaluate an infant hearing screening program utilizing the high risk register (HRR) and auditory brainstem response (ABR). DESIGN: A cost-effectiveness analysis of the screening program employing a retrospective cohort identified by chart review. The analysis was performed on a hypothetical cohort of 100,000 births and the results compared with a base model derived from literature review. SETTING: Mount Sinai Hospital, New York City, an urban, tertiary care institution. PATIENTS: All infants born between November 1990 and October 1993, approximately 16,500. Cost-effectiveness analysis focused on test results of 420 infants failing the HRR and 381 who subsequently received ABR. RESULTS: Analysis of the Mount Sinai Hospital (MSH) protocol showed it to be less cost-effective than other similar programs. The cost per hearing loss was far more at MSH than that found elsewhere. Further, the MSH program was ineffective in detecting infants with congenital hearing loss--identifying only one case between 1990 and 1993. Analysis of high risk criteria finds a low incidence of family history of hearing loss in the Mount Sinai cohort while other studies find a very high incidence. CONCLUSIONS: It appears that the poor performance of the MSH protocol is due to low specificity and sensitivity of the HRR. This generates a costly and ineffective program as follow-up exams focus on ruling-out false-positives rather than correctly identifying true hearing losses. Further evaluation is needed to determine whether changes in the application of the HRR or utilization of newer, low-cost tests such as otoacoustic emissions (OAE) may be effective in universal infant hearing screening.


Subject(s)
Audiometry, Evoked Response/economics , Hearing Loss, Sensorineural/diagnosis , Neonatal Screening/economics , Cohort Studies , Cost-Benefit Analysis , Decision Trees , Evoked Potentials, Auditory, Brain Stem , Hearing Loss, Sensorineural/congenital , Hospitals, Urban , Humans , Infant, Newborn , New York City , Retrospective Studies , Risk Factors , Sensitivity and Specificity
9.
J Community Health ; 21(3): 183-98, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8726209

ABSTRACT

We examined the prevalence of, and factors associated with unmet health service needs among persons with HIV disease. Data were examined from 1,851 participants in the U.S. AIDS Cost and Service Utilization Study, drawn from 26 medical care providers in 10 cities. Geographic areas with large numbers of AIDS cases, and health care providers within them were chosen as study sites. After completing a screener questionnaire, potential participants at each site were stratifed by illness stage, HIV exposure route, and insurance status; a systematic random sample within those strata were selected for the study. Participants completed a comprehensive survey of HIV-related service use and costs, which also asked them to identify unmet health service needs. Analyses identified the relationship between unmet needs and: stage of illness, type of insurance, source of care, living arrangement, and AIDS prevalence of respondents' geographic region. At least one unmet need was reported by 20% of the sample. Needs for non-institutional services, e.g, dental care, mental health, and medications were more likely to be unmet than need for emergency room and hospital care. While most factors significantly affected the odds of having an unmet need, the greatest effects were found for private insurance and HIV asymptomatic status, both of which decreased the odds of unmet needs by approximately 50%. These findings suggest that insurance coverage for services required during the chronic phase of HIV illness is inadequate and should be augmented.


Subject(s)
HIV Infections/psychology , Health Services Needs and Demand , Patient Satisfaction , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/psychology , Adult , Continuity of Patient Care/statistics & numerical data , Female , HIV Infections/epidemiology , Health Policy , Health Services Needs and Demand/statistics & numerical data , Humans , Male , Patient Care Team/statistics & numerical data , Patient Satisfaction/statistics & numerical data , United States/epidemiology
10.
Pharmacoeconomics ; 9(3): 211-30, 1996 Mar.
Article in English | MEDLINE | ID: mdl-10160098

ABSTRACT

Screening programmes for cervical cancer have been credited with reducing the incidence of and mortality from cervical cancer. The main components of these screening programmes are: (i) their level of organisation; (ii) the age at which women begin screening; (iii) the age at which women discontinue screening; (iv) the interval between repeat screens; (v) the frequency at which the programmes provide screening; and (vi) the response to an abnormal screening test. However, not all screening programmes are equally efficient and differences in programme components can result in big differences in their cost effectiveness. Studies that employ cost-effectiveness analysis (CEA) to examine the efficiency of different programme components can inform the development of cost-effective programmes. This article presents findings of an international review of cost-effectiveness studies of cervical cancer screening. These studies consistently find that certain types of programmes are more cost effective than others. Programmes that are centrally organised and implemented by the public sector are reported to be more cost effective than those that use public funds for screening at other medical visits (convenience screening), or those that provide guidelines for healthcare professionals and the public to promote spontaneous discretionary screening. There is also substantial agreement about the cost effectiveness of other programme components. When multiple screenings are possible, studies report that they should generally begin at age 25 to 35 years and end at age 65 to 70 years, although it is important that older women have 3 normal Papanicolaou (Pap) smears before the discontinuation of screening. The interval for repeat screens that is reported to provide the best balance between cost and life-years saved is between 3 and 5 years. However, when a choice must be made between screening more women fewer times, or screening fewer women more times, most studies indicate that it is more cost effective to prioritize resources to obtain at least one screening for each woman. The screening of previously unscreened and high-risk populations has been shown to be especially cost effective. Despite this agreement, many studies report that models of the cost effectiveness of screening for cervical cancer are sensitive to a number of parameters. Changes in the attendance rate of the programme, the quality of the Pap smear, and the cost of the Pap smear can markedly change the cost effectiveness of a screening programme. Finally, this review discusses different perspectives of social choice analysis (e.g. CEA and cost-benefit analysis), when the objective is to prevent cervical cancer and the options are to screen, detect and treat, to reduce behavioural risk factors, and/or to pursue promising biological research.


Subject(s)
Mass Screening/economics , Uterine Cervical Neoplasms/prevention & control , Cost-Benefit Analysis , Female , Humans , Models, Theoretical , Papanicolaou Test , Uterine Cervical Neoplasms/economics , Uterine Cervical Neoplasms/epidemiology , Vaginal Smears/economics
11.
Article in English | MEDLINE | ID: mdl-8645784

ABSTRACT

This study sought to identify the prevalence of unstable housing situations, and for whom they occurred, and to examine differences in health care utilization by housing status. Housing status and inpatient and outpatient health care utilization of 1,851 HIV-infected individuals was ascertained through interviews. Nine percent of respondents were in unstable housing situations. Unstable housing was associated with significantly lower functional status. The unstably housed were more likely to visit an emergency room (p < 0.05) and had fewer ambulatory visits than persons with stable housing (p < 0.03). They incurred nearly five more hospital days and their average hospitalization was approximately 1.5 days longer than the stably housed, although these differences were not significant. Utilization of ambulatory care is lower among unstably housed persons with HIV disease, which may have led to their increased reliance upon emergency rooms and hospitals. Helping HIV-infected individuals maintain adequate housing could reverse this pattern.


Subject(s)
HIV Infections , Health Services/statistics & numerical data , Ill-Housed Persons , Population Dynamics , Adult , Analysis of Variance , Case-Control Studies , Female , HIV Infections/epidemiology , Humans , Logistic Models , Male , Odds Ratio , Prospective Studies , United States/epidemiology
12.
Soc Work Health Care ; 22(4): 1-20, 1996.
Article in English | MEDLINE | ID: mdl-8807735

ABSTRACT

Pediatric AIDS is a continuing problem because of maternal transmission. Medical management is often complicated by the loss of one or both parents and adverse home environments. This study explores the cost of inpatient and clinic care of children admitted with AIDS in 1988 or 1989 at Mount Sinai Medical Center in New York City, and also examines the social severity of the cases. Blue Shield allowances were used to price clinic visits and tests, and prices in a drug trade publication were used to determine medication costs. Inpatient costs calculated per person-month at risk amounted to $48,000 per year. Costs per person-month of the clinic care averaged $461 (38% of which was for drugs), annualized to around $5,500. These costs are higher than those shown by previous studies. A few cases requiring intensive inpatient services accounted for a large percentage of costs. The social severity analysis, based on the family environment at first admission and later, revealed that households were often stressed by chronic illnesses, drug abuse, marital problems and poor residential quality. Given the circumstances in which pediatric AIDS develops, the activities of social workers to strengthen families are essential to facilitating compliance, maintaining health and minimizing use of the hospital.


Subject(s)
Acquired Immunodeficiency Syndrome/economics , Child, Hospitalized , Health Care Costs , Acquired Immunodeficiency Syndrome/psychology , Child , Child, Hospitalized/education , Child, Hospitalized/psychology , Cost of Illness , Family/psychology , Humans , New York City , Retrospective Studies , Social Support
13.
Soc Work Health Care ; 22(4): 21-34, 1996.
Article in English | MEDLINE | ID: mdl-8807736

ABSTRACT

The development of cost effective models of hospital care and discharge planning for people with HIV is a vital policy issue. However, almost no data exist evaluating cost and quality differences in alternate hospital models of care. This empirical study retrospectively evaluates social work discharge planning for patients with HIV disease in two hospital care models: a cluster AIDS unit and general inpatient site beds. The independent effect of each hospital model of care on length of stay is assessed in a multivariate analysis, controlling for level of care needs and other social and clinical factors. Results reveal that the cluster AIDS unit, where a specialized AIDS social work staff works in collaboration with the interdisciplinary AIDS team, is associated with a significant reduction in hospital length of stay for persons with HIV disease and complex discharge planning needs. These results support the hypothesis that discharge planning services, performed by specialized social workers, are a cost effective investment for hospitals treating patients with complex chronic conditions, such as AIDS. Further research should be developed to systematically evaluate the cost effectiveness of hospital-based social workers, using prospective experimental designs, in order to establish the net impact of social work discharge planning services on patient and family outcomes and institutional and social costs.


Subject(s)
Acquired Immunodeficiency Syndrome/economics , Hospital Costs , Hospital Units/organization & administration , Models, Economic , Patient Discharge/economics , Social Work Department, Hospital , Acquired Immunodeficiency Syndrome/therapy , Adult , Cost-Benefit Analysis , Female , Humans , Length of Stay , Male , Multivariate Analysis , Retrospective Studies
16.
J Assoc Nurses AIDS Care ; 6(5): 20-5, 1995.
Article in English | MEDLINE | ID: mdl-8785412

ABSTRACT

The Visiting Nurse Service of New York and Empire Blue Cross and Blue Shield implemented in 1990 the "At Home Options Program" (AHOP), an enhanced package of home care and other noninpatient services for HIV-positive clients. AHOP aims to reduce total treatment costs and hospital days. Clients (N = 52) completed mailed satisfaction surveys. Overall, clients were very satisfied with AHOP services. Clients expressed concerns, however, about the uneven quality of substitute paraprofessionals, and said they needed easier access to a knowledgeable healthcare professional. Operational concerns included inadequate information dissemination and administrative oversights. Findings will inform subsequent program activities.


Subject(s)
Community Health Nursing/organization & administration , HIV Infections/nursing , Home Care Services/organization & administration , Patient Satisfaction , Adult , Cost Control , Female , Humans , Length of Stay , Male , Middle Aged , Nursing Evaluation Research , Outcome Assessment, Health Care , Surveys and Questionnaires
19.
Radiology ; 195(3): 633-7, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7753986

ABSTRACT

PURPOSE: To determine the frequency with which stereotaxic core biopsy of the breast obviated diagnostic surgical biopsy and to estimate the savings in cost of diagnosis with this procedure. MATERIALS AND METHODS: Stereotaxic core biopsy of 182 nonpalpable, mammographically evident lesions was performed, and data from clinical follow-up were obtained. Savings in cost were assessed by using national Medicare reimbursement data and a relative value system based on national physician reviews (Relative Values for Physicians [RVP]). RESULTS: Stereotaxic core biopsy replaced a surgical procedure in 140 of 182 patients. The mean adjusted direct savings in cost per stereotaxic core biopsy were $893 (Medicare) or $1,491 (RVP). Use of stereotaxic core biopsy decreased the cost of diagnosis by 52% (RVP) or 55% (Medicare). CONCLUSION: Stereotaxic core biopsy obviated surgical biopsy for most nonpalpable lesions sampled, resulting in a greater than 50% reduction in biopsy costs. If these results were generalizable to the national level, annual savings would approach $200 million.


Subject(s)
Biopsy, Needle/economics , Breast/pathology , Stereotaxic Techniques/economics , Biopsy, Needle/methods , Breast Neoplasms/diagnosis , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/economics , Cost Savings , Cost-Benefit Analysis , Female , Humans , Mammography , Medicare , Relative Value Scales , United States
20.
Health Serv Res ; 29(5): 549-68, 1994 Dec.
Article in English | MEDLINE | ID: mdl-8002349

ABSTRACT

OBJECTIVE: This study describes demographic characteristics of pediatric AIDS patients, describes hospital and community-based service utilization patterns, and analyzes medical and social support service usage patterns with respect to patient demographic characteristics, clinical trial participation, functional/developmental status, and social environment. DATA SOURCES AND STUDY SETTING: Data reported in this study are from the AIDS Costs and Service Utilization Survey (ACSUS) and cover the six-month period beginning March 1991 (N = 135). Pediatric patients who sought care for HIV-related problems were sampled at seven different hospitals in five metropolitan regions of the United States. All of the participating hospitals had clinics specifically serving pediatric patients infected with HIV. The sample consists of HIV-positive patients who had had at least one HIV-related symptom or condition. STUDY DESIGN: A stratified probability sample design guided the sampling strategy, which included oversampling in two large hospitals from two of the five metropolitan areas. Survey data cover an 18-month time period of health care utilization, cost, and financing information from HIV-infected patients and their providers. Utilization measures are standardized to a six-month period. Per capita income, family structure, informal personal network, functional status, and clinical trial participation are tested for associations with patterns of utilization. In addition, a weighted ten-point social severity scale was developed to assess family/household stability. DATA COLLECTION: Data were collected through a screener instrument completed by the person accompanying the child to a hospital clinic visit (usually a a parent), and through two interviews conducted in person with the patients' primary caregivers. Data from the questionnaires were coded and assembled into computerized SAS analysis files by WESTAT: PRINCIPAL FINDINGS: Children in this sample are 62 percent African American, 25 percent Hispanic, and 10 percent White. Medicaid is the primary payer for 92 percent. Mean per capita income is $3,440. Fewer than one-half (41 percent) of the families of the children receive Aid to Families with Dependent Children (AFDC). (AFDC). Within the six-month period, approximately one-third of the sample (29.6 percent) was hospitalized. Mean length of stay was 16.0 days. Clinical trial participation was positively related to mean number of hospital clinic visits and receipt of formal (paid) home care. There were no differences in use of community clinic, mental health, and inpatient facilities by clinical trial status. Participation in clinical trials was positively related to income and negatively related to social severity. In four cities, emergency room use was consistently lower for clinical trial participants than for nonparticipants. CONCLUSIONS: Data from the first six months of the ACSUS pediatric sample suggest that participation in clinical trials may bring about access to social services that appear to reduce emergency room use. However, the findings reported here are descriptive and exploratory. Further multivariate, nonparametric analyses of the full 18-month provider-patient merged data set are necessary to confirm the simple correlations found in this study.


Subject(s)
Acquired Immunodeficiency Syndrome , Activities of Daily Living , Health Services Research , Health Services/statistics & numerical data , Social Support , Acquired Immunodeficiency Syndrome/classification , Acquired Immunodeficiency Syndrome/economics , Acquired Immunodeficiency Syndrome/physiopathology , Acquired Immunodeficiency Syndrome/therapy , Aid to Families with Dependent Children , Child , Child, Preschool , Clinical Trials as Topic , Female , Humans , Infant , Infant, Newborn , Longitudinal Studies , Male , Medicaid , Sampling Studies , Severity of Illness Index , Socioeconomic Factors , United States , United States Agency for Healthcare Research and Quality
SELECTION OF CITATIONS
SEARCH DETAIL
...